Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child.

1. Goedert JJ, Vitale F, Lauria C, et al; Classic Kaposi’s Sarcoma Working Group. Risk factors for classical Kaposi’s sarcoma. J Natl Cancer Inst. 2002;94:1712-1718. 2. Wang CY, Schroeter AL, Su WP. Acquired immunodef ic iency syndrome-re la ted Kaposi’s sarcoma. Mayo Clin Proc. 1995;70: 869-879. 3. Oettle AG. Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum. 1962;18: 330-363. 4. Templeton AC, Hutt MS. Distribution of tumours in Uganda. Recent Results Cancer Res. 1973;41:1-22. 5. Dutz W, Stout AP. Kaposi’s sarcoma in infants and children. Cancer. 1960;13: 684-694. 6. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer. 1993;72:17791783. 7. Penn I. Kaposi’s sarcoma in transplant recipients. Transplantation. 1997;64:669-673. 8. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am. 1996;10:997-1010. 9. Ron IG, Kremer I, Lowenstein A, Chaitchik S. Conjunctival involvement in classic (indolent) HIV negative Kaposi’s sarcoma. Br J Ophthalmol. 1994;78:488-489. 10. Kalinske M, Leone CR. Kaposi’s sarcoma involving eyelid and conjunctiva. Ann Ophthalmol. 1982;14:497-499. 11. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865-1869. 12. Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004; 43:698-704. 13. Arnold M, Geilen CC, Coupland SE, et al. Unilateral angiolymphoid hyperplasia wi th eos inophi l i a involv ing the le f t arm and hand. J Cutan Pathol. 1999;26: 436-440. Neovascular Glaucoma From Advanced Coats Disease as the Initial Manifestation of Facioscapulohumeral Dystrophy in a 2-Year-Old Child